INTRODUCTION
Living donor liver transplantation (LDLT) is the method of choice for expanding the liver donor pool in many countries where the cadaveric organ supply is insufficient. 1,2 The most important advantages of LDLT are an easily available liver graft, ability to perform a planned and elective surgery, and a shorter cold ischemia time. 1,2 Despite of these advantages, safety of living liver donors (LLDs) is still a matter of debate. Increase in the number of studies addressing with morbidity and mortality in LLDs reduced the interest and a motivation in performing LDLT in the western world; significantly. Studies in current literature reported an overall morbidity and mortality following living donor hepatectomy (LDH) as 0-67% and 0.1-1%, respectively. 1-3 Biliary complications following the LDH procedure are the most common of all the complications. Management of intraoperative or postoperative biliary complications vary from a strategy of “wait and see” to a complex and technically demanding surgical procedure such as hepaticojejunostomy (HJ). Percutaneous transhepatic biliary tract drainage (PTBD: external-internal, external), percutaneous perihepatic bilioma drainage (transhepatic or transperitoneal) and endoscopic retrograde cholangiopancreatography (ERCP) are among the treatment options for biliary complications. However, there is a lack of consensus regarding timing and choice of treatment algorithm and which LLDs should undergo HJ. This study aims to present our treatment algorithm of biliary complications in LLDs and our technique for PTBD catheter assisted HJ in necessary cases.